No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer.
OBJECTIVE
Insulin-like growth factors (IGF) regulate a wide range of biological functions including cell proliferation, differentiation, and apoptosis through paracrine and autocrine mechanisms. Accordingly, the present study analyzed polymorphisms of IGF genes and their impact on the prognosis for patients with colorectal cancer.


METHODS
Four hundred and two consecutive patients with curatively resected colorectal adenocarcinoma were enrolled in the present study. The genomic DNA was extracted from fresh colorectal tissue and 8 polymorphisms of IGF genes determined using a real-time polymerase chain reaction genotyping assay.


RESULTS
PATHOLOGIC STAGES AFTER SURGERY WERE AS FOLLOWS: stage 0/I (n=85, 21.1%), stage II (n=147, 36.6%), stage III (n=145, 36.1%), and stage IV (n=25, 6.2%). Multivariate survival analysis including stage, age, site of disease, and carcinoembryonic antigen level showed that the progression-free survival for patients with the IGF2 +1280 GG genotype was slightly better than for the patients with the combined IGF2 +1280 AA and AG genotype (p=0.056), although there was no significant difference in the overall survival. However, the other polymorphisms were not associated with survival.


CONCLUSIONS
None of the 8 IGF1 or IGF2 gene polymorphisms investigated in this study were found to be independent prognostic markers for Korean patients with surgically resected colorectal cancer.
Division of Hematology/Oncology, Dongguk University College of Medicine, Gyeongju, Korea.
Yoon Young
YY
Cho
Jong Gwang
JG
Kim
Yee Soo
YS
Chae
Sang Kyun
SK
Sohn
Byung Woog
BW
Kang
Joon Ho
JH
Moon
Seong Woo
SW
Jeon
Jun Seok
JS
Park
Jin Young
JY
Park
Gyu Seog
GS
Choi